Showing results (451-460 of 1,148) with videos related to

Sort By:
Pageof 115
JHEP Reports : Innovation in Hepatology|May 20, 2021
Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantationMichael Praktiknjo, Jasmin Abu-Omar, Johannes Chang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2016
Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: A prospective multicentre studyChristian Jansen, Christopher Bogs, Wim Verlinden, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosisDaniel Markwardt, Lesca Holdt, Christian Steib, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 24, 2017
Increased myocardial contractility identifies patients with decompensated cirrhosis requiring liver transplantationChristian Jansen, Alexander Cox, Robert Schueler, et al.
European Journal of Heart Failure|July 17, 2021
Cardiac output states in patients with severe functional tricuspid regurgitation: impact on treatment success and prognosisMatthias Unterhuber, Karl-Patrik Kresoja, Christian Besler, et al.
The Lancet. Gastroenterology & Hepatology|February 20, 2026
Safety, pharmacokinetics, and preliminary efficacy of VS-01, an intraperitoneal liposomal infusion, in patients with decompensated liver cirrhosis, ascites, and covert hepatic encephalopathy: a phase 1b, first-in-human, open-label, non-randomised, single ascending and multiple dose studyFrank Erhard Uschner, Martin McCoy, Olaf Tyc, et al.
Plos One|August 25, 2021
Role of circulating angiogenin levels in portal hypertension and TIPSAlexander Queck, Frank E Uschner, Philip G Ferstl, et al.
Oncotarget|December 15, 2018
The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertensionFrank Erhard Uschner, Florian Schueller, Ivelina Nikolova, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2014
Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertensionJonel Trebicka, Cyrus Wix, Matthias von Heydebrand, et al.
The American Journal of Pathology|January 17, 2015
The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic ratsLen Verbeke, Ricard Farre, Bert Verbinnen, et al.
Pageof 115